Business Context and Reporting Period
Company: Eastman Kodak Company
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 1995
Reporting Basis: Unaudited financial statements prepared in accordance with 1994 Annual Report policies.
Key Financial Metrics
| Metric (in millions) | Q3 1995 | Q3 1994 | YTD 1995 | YTD 1994 |
|---|---|---|---|---|
| Total Revenues | $3,877 | $3,531 | $11,078 | $9,779 |
| Net Earnings | $338 | $193 | $977 | $539 |
| Earnings Per Share (EPS) | $0.99 | $0.57 | $2.86 | $1.61 |
| Gross Profit Margin | 47.9% | 44.3% | 48.3% | 46.2% |
| Operating Cash Flow (YTD) | $1,439 | $850 | - | - |
| Cash & Equivalents (End of Period) | $1,268 | $585 | - | - |
| Total Debt (Short + Long Term) | $1,065 | $1,031 | - | - |
Note: Debt figures derived from Short-term borrowings ($412M) and Long-term borrowings ($653M) as of Sept 30, 1995.
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 8% in Q3 and 12% year-to-date (YTD) compared to 1994. Excluding the Qualex acquisition impact, organic sales grew 6% in Q3 and 9% YTD.
- Profitability Surge: Net earnings rose 75% in Q3 and 81% YTD. This was driven by volume gains, manufacturing productivity, lower interest expense, and favorable foreign currency effects.
- Margin Expansion: Gross profit margin improved by 3.6 percentage points YTD (48.3% vs 46.2%), excluding 1994 purchase accounting adjustments related to Qualex.
- Cash Position: Cash and cash equivalents decreased $752 million YTD to $1,268 million, primarily due to $1.3 billion in tax payments related to the divestiture of non-imaging health businesses and investing activities.
- Segment Performance: Consumer Imaging earnings rose 51% in Q3; Commercial Imaging earnings rose 55% in Q3.
Outlook, Risks, and Unusual Items
Management Commentary and Guidance
- Stock Repurchase: On October 17, 1995, the Company announced a plan to repurchase up to $1 billion of common stock over the next nine months.
- Pension Contribution: Intention to contribute approximately $500 million of Kodak stock to its U.S. defined benefit pension plan.
- Liquidity: Projected operating cash flows are expected to be adequate to support operations, capital expenditures, and dividends.
Risks and Contingencies
- Antitrust Litigation: A jury verdict in Image Technical Service, Inc. v. Eastman Kodak Company awarded plaintiffs $23.9 million (subject to trebling). The Company intends to appeal. Two similar cases (Nationwide and A-1 Copy Center) are pending with discovery expected to accelerate.
- Environmental Liability: The Company is a potentially responsible party (PRP) at approximately 25 Superfund sites. Management expects future costs to be immaterial. Participation in the EPA TSCA program is expected to result in $1 million in penalties.
Unusual Items
- 1994 Comparability: 1994 results were adversely affected by ~$60 million in Q3 and ~$90 million YTD due to Qualex acquisition costs and asset valuation charges. 1994 YTD also included a $13 million extraordinary charge for early debt extinguishment.
- Discontinued Operations: 1994 included losses from divested non-imaging health businesses (Sterling Winthrop, L&F Products, Clinical Diagnostic Division).
Investor Verification Checklist
- Antitrust Appeal Outcome: Monitor the appeal of the $23.9 million jury verdict and the status of the two pending consolidated class actions.
- Stock Repurchase Execution: Verify the pace and funding source (cash reserves vs. new borrowings) of the announced $1 billion buyback.
- Foreign Currency Sensitivity: Assess the impact of currency fluctuations on future margins, given the significant favorable effect in 1995.
- Inventory Levels: Review the $424 million increase in inventories YTD and its impact on working capital efficiency.
- Environmental Costs: Confirm that Superfund and EPA TSCA liabilities remain within the "immaterial" threshold projected by management.